HCG.NS - Risk

Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 62/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±30.8% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (-0.0x).

Beta (Market Relation)

-0.01x

Defensive

Volatility (5Y p.a.)

30.8% p.a.

5-Year Horizon

Max Drawdown (5Y)

-32.8%

5-Year Horizon

Sharpe Ratio

0.54

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-13.8%
3 Years	32.0%	-32.8%	0.48	+17.8%
5 Years	30.8%	-32.8%	0.54	+19.3%
10 Years	35.3%	-80.4%	0.22	+10.2%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

🔴 High valuation risk: Avg P/E of 380.1 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (30.8% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -80.4% in the extended horizon.